Close
Smartlab Europe
Inizio Ignite

Clinical Trials

Sarclisa by Sanofi has EC Approval to Treat Multiple Myeloma

In order to treat multiple myeloma in adults, Sarclisa from Sanofi in combination with a regimen of lenalidomide, bortezomib, and dexamethasone (VRd) has been granted approval by the European Commission. It is well to be noted that Sarclisa has received...

UK government, Manufacturing, Investment, Clinical trials

The UK government will improve manufacturing and commercialisation as it seeks to maximise the value of the life sciences sector growth for the country's economy. In a new Life Sciences sector growth plan, the government established a six-point action plan...

Role of Technology in Enhancing Patient Engagement in Trials

In the past few years, there has been a positive movement toward using technology to change how patients are engaged and how they stay with a practice. A lot of different kinds of technology are changing the way clinical...

AI in Alzheimer Drug Development to Enhances Clinical Trials

Scientists applied artificial intelligence (AI) to reanalyse a clinical trial for AI in Alzheimer Drug Development, identifying a group of patients who responded to medical treatment. The study shows that AI can help design future clinical trials to be...

Nipah Virus Vaccines Enter Clinical Trials in Bangladesh

Two Vaccines against the Nipah virus, a deadly bat-borne virus, are scheduled to begin human clinical trials in Bangladesh, while intriguing medication candidates have demonstrated the ability to treat and prevent infection. While Nipah case numbers remain low, climate change...

Merck to Initiate Phase 3 Trials for Investigational Once-Monthly HIV Prevention Pill

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the initiation of the EXPrESSIVE Phase 3 clinical trials, evaluating the safety and efficacy of MK-8527, an investigational once-monthly, oral nucleoside reverse transcriptase translocation...

CDSCO Moves to Online Submission for CGTP Trial Applications

As part of its continued efforts to streamline operations through digitisation, the Central Drugs Standard Control Organisation (CDSCO) has transitioned from offline to online acceptance of clinical trial applications for cell and gene therapies products (CGTP). The agency has also...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »